EDGAR Filing Documents for 0001171843-13-002164

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001171843-13-002164

Filing Date

2013-05-21

Accepted

2013-05-21 16:44:52

Documents

Period of Report

2013-02-28

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	f6k_052113.htm	6-K	19560
2	EXHIBIT 99.1	exh_991.htm	EX-99.1	1069584
3	EXHIBIT 99.2	exh_992.htm	EX-99.2	372950
4		logo.gif	GRAPHIC	7105
5		kpmg.jpg	GRAPHIC	5369
6		kpmgsig.jpg	GRAPHIC	4884
	Complete submission text file	0001171843-13-002164.txt		1487352

Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3

Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)